Otxone SL 250mg/125mg Injection
Marketer
Yew Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Otxone SL 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be solely under medical supervision; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Otxone SL 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Otxone SL 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Otxone SL 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Otxone SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Otxone SL 250mg/125mg Injection works:
The injectable formulation Otxone SL (250mg/125mg Ceftriaxone/Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Otxone SL 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Otxone SL, 250mg/125mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Otxone SL 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Otxone SL 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Otxone SL 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Otxone SL 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alterations for Otxone SL 250mg/125mg Injection are unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Otxone SL 250mg/125mg Injection :
Should you inadvertently skip a dose of the Otxone SL 250mg/125mg injection, seek medical advice.
Facts to Know About Otxone SL 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently